FLT1 and neoplasm: This is supported by Kaplan et al. [38], who demonstrated that antibody-mediated inhibition of VEGFR1 function, or the removal of VEGFR1 cells from the bone marrow, abrogated the formation of pre-metastatic clusters and prevented tumour metastasis to bone.